Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials

PRIMARY OBJECTIVES:

I. To identify participant-level factors affecting recruitment of potentially eligible
participants in AIDS Malignancy Clinical Trials Consortium (AMC) studies at core and
affiliated sites.

SECONDARY OBJECTIVES:

I. To describe the socio-demographic characteristics for participation and non-participation
in AMC clinical trials among all approached volunteers across AMC sites.

II. To characterize socio-demographic characteristics with motivation and decision making
among those who consented to participate in an AMC trial.

III. To identify the perceived barriers associated with clinical trial participation among
those who did not consent to participate in an AMC clinical trial.

IV. To better understand how potential study volunteers learn about AMC clinical trials and
by what means are they referred to a particular study.

OUTLINE:

Participants complete the Improving Participation in AMC Clinical Trials (IMPACTS) survey
comprising questions about socio-demographic information and clinical trial participation.

Inclusion Criteria:

- HIV-infected participants

- Cancer or anal dysplasia diagnosis

- Offered informed consent on an AMC interventional clinical trial

- Ability to understand and the willingness to sign a written informed consent document

Exclusion Criteria:

- Inability to provide informed consent